Consensus IDEXX Laboratories, Inc. Sao Paulo

Stocks

I1DX34

BRI1DXBDR001

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 09:48:23 03/09/2026 pm IST			5-day change	1st Jan Change
542.81 ^BRL	-5.18%		-5.18%	-28.14%

18/08	IDEXX Laboratories, Inc. - Analyst/Investor Day
11/08	IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment	MT

Evolution of the Average Target: IDEXX Laboratories, Inc.

Evolution of the Target Price: IDEXX Laboratories, Inc.

Changes in Analyst Recommendations: IDEXX Laboratories, Inc.

5beaf424abee048f6cd9aa9d85f19144.X4AoBsOncugqDCebZd7PKID2cRcZ_05hvE1gEMKNl7k.AM4RN_bMIqpgQ2jqUIekT-2CJiFWlz9Wiz1XYrjButYz32JjgMlBrhhqHw~ad078daf9c4b8100bd4ed8d57665e4c4

Analysts' recommendations: IDEXX Laboratories, Inc.

11/08	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
05/08	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
05/08	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
05/08	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
27/07	Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says	MT
27/07	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
13/07	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT
06/05	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $665 From $655	MT
06/05	Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785	MT
28/04	UBS Adjusts Price Target on IDEXX Laboratories to $640 From $730, Maintains Neutral Rating	MT
27/04	Jefferies Adjusts Price Target on IDEXX Laboratories to $785 From $820, Maintains Buy Rating	MT
15/04	Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target	MT
14/04	Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating	MT
31/03	Stifel Nicolaus Adjusts IDEXX Laboratories PT to $675 From $775, Maintains Buy Rating	MT
09/02	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating	MT
05/02	Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating	MT
05/02	Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850	MT
03/02	Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830	MT
03/02	UBS Adjusts IDEXX Laboratories PT to $730 From $750	MT
03/02	Leerink Partners Adjusts Price Target on IDEXX Laboratories to $760 From $785	MT
03/02	BTIG Adjusts Price Target on IDEXX Laboratories to $800 From $830	MT
03/02	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $655 From $700	MT
09/12	Barclays Initiates IDEXX Laboratories With Overweight Rating, $850 Price Target	MT
10/11	Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700	MT
04/11	UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating	MT